Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia (CXL)
Randomized Study of Safety and Effectiveness of Corneal Collagen Crosslinking and Intacs for Treatment of Keratoconus and Corneal Ectasia
Sponsor: Cornea and Laser Eye Institute
Listed as NCT01112072, this PHASE3 trial focuses on Corneal Ectasia and Keratoconus and remains ongoing. Sponsored by Cornea and Laser Eye Institute, it has been updated 13 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Unknown PHASE3
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Apr 2022 — Mar 2023 [monthly]
Active Not Recruiting PHASE3
▶ Show 8 earlier versions
-
Jun 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE3
-
Feb 2021 — Jun 2021 [monthly]
Active Not Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE3
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
-
Feb 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE3
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cornea and Laser Eye Institute
For direct contact, visit the study record on ClinicalTrials.gov .